alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-Glcp

Term ID

CHEBI:149036

Synonyms

(2R,3R,4R)-2-[(2R,3S,4R,5R,6S)-4,6-dihydroxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
2-deoxy-4-O-alpha-L-threo-hex-4-enopyranuronosyl-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose
WURCS=2.0/2,2,1/[a2122h-1a_1-5_2*NSO/3=O/3=O_6*OSO/3=O/3=O][a21EEA-1a_1-5]/1-2/a4-b1

Definition

A disaccharide derivative consisting of alpha-L-threo-hex-4-enopyranuronic acid and 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose residues joined by a (1->4) glycosidic bond.

References

GlyGen:G30702UA
GlyTouCan:G30702UA

Ontology

ChEBI ( EBI )

Relationships

is a type of: disaccharide derivative enol oligosaccharide sulfate

disaccharide derivative enol oligosaccharide sulfate Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-Glcp

Phenotype where environments contain alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-Glcp

Phenotype modified by environments containing alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-Glcp

Human Disease / Model Data